Hybrid MLOps Engineer - Azure & LLMs

Pharmacy2U Ltd; Leeds; Hybrid; GBP 70,000 - 100,000; Full time

Benefits offered by this job

Pension plan

Sick pay

Long-service awards

Professional registrations covered

Cycle to Work

Green Car schemes

Flexible hybrid working

Employee assistance

Job summary

Pharmacy2U Ltd. is seeking a Machine Learning Operations Engineer to own production-grade ML and LLM services on Azure, driving end-to-end MLOps. You will design CI/CD pipelines, manage model registration, and implement safe deployment strategies across environments, ensuring governance and reliability.

The role may include out-of-hours on-call rotations in a hybrid Leeds office. Ideal candidates have strong Python skills, experience with ML frameworks, and a DevOps/SRE background with CI/CD,

Qualifications

• Strong Python engineering skills with ML framework experience.
• Experience in regulated environments and data privacy/auditability.
• Hands-on DevOps/SRE background including CI/CD and IaC.

Responsibilities

• Design and operate CI/CD pipelines for ML models and LLM prompt-flows, including build, test, deployment, and rollback.
• Own model registration and promotion across environments with governance and auditability.
• Implement safe deployment strategies (blue/green, canary, champion/challenger).
• Package and deploy containerised inference services and batch pipelines with repeatability.

Skills

Python

ML frameworks

CI/CD

Docker

Kubernetes

Azure

Observability

Tools

Azure Machine Learning

Git

Job description

Pharmacy2U Ltd. is seeking a Machine Learning Operations Engineer to own production-grade ML and LLM services on Azure, driving end-to-end MLOps. You will design CI/CD pipelines, manage model registration, and implement safe deployment strategies across environments, ensuring governance and reliability.

The role may include out-of-hours on-call rotations in a hybrid Leeds office. Ideal candidates have strong Python skills, experience with ML frameworks, and a DevOps/SRE background with CI/CD,